Corpus Intelligence IC Memo — WAGONER HOSPITAL AUTHORITY 2026-04-26 09:55 UTC
IC Memo — WAGONER HOSPITAL AUTHORITY
Investment Committee Memorandum | OK | 100 beds | Grade D | EBITDA uplift $1.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

WAGONER HOSPITAL AUTHORITY

CCN 370166 | WAGONER, OK | 100 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

WAGONER HOSPITAL AUTHORITY is a 100-bed safety-net/medicaid heavy in WAGONER, OK with $21.9M in net patient revenue and a -24.0% operating margin. The hospital serves a payer mix of 14.0% Medicare, 58.1% Medicaid, and 27.9% commercial.

Thesis: Turnaround. Our ML models identify $1.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -24.0% to -16.7% (+736bps).

Net Revenue HCRIS$21.9M
Current EBITDA COMPUTED$-5.3M
Operating Margin COMPUTED-24.0%
Occupancy HCRIS35.3%
Revenue / Bed COMPUTED$219K
Net-to-Gross HCRIS37.9%
Distress Probability ML66.2%

2. Market Context & Competitive Position

147
OK Hospitals
-8.8%
State Median Margin
42
Comparable Hospitals

OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of -24.0% places it below the state median. Among 42 size-comparable peers (50-200 beds), the median margin is -2.7%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (50-200), prioritizing same-state peers. 42 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WAGONER HOSPITAL AUTHORITY (Target)OK100$21.9M-24.0%
OKLAHOMA HEART HOSPITALOK97$342.0M-2.8%
STILLWATER MEDICAL CENTEROK52$270.2M-9.9%
INTEGRIS SOUTHWEST MEDICAL CENOK169$267.6M-13.5%
HILLCREST HOSPITAL SOUTHOK152$218.9M4.9%
SAINT FRANCIS HOSPITAL SOUTHOK104$198.3M34.4%
ST ANTHONY SHAWNEE HOSPITALOK57$169.2M-6.1%
MCBRIDE CLINIC ORTHOPEDIC HOSPOK68$166.9M-5.0%
MERCY HOSPITAL ARDMOREOK140$158.8M-1.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$460K+210bp18mo
Cost to Collect4.5%2.5%$438K+200bp12mo
Denial Rate Reduction12.0%6.5%$434K+198bp12mo
A/R Days Reduction5200.0%3800.0%$267K+122bp9mo
Clean Claim Rate88.0%96.0%$14K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$460K
Cost to Collect
$438K
Denial Rate Reduction
$434K
A/R Days Reduction
$267K
Clean Claim Rate
$14K
Total EBITDA Uplift$1.6M
Current EBITDA$-5.3M
+ RCM Uplift+$1.6M
Pro Forma EBITDA$-3.7M
Current Margin-24.0%
Pro Forma Margin-16.7%
WC Released (1x)$840K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-8.1M$-18.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-8.1M$-23.1M0.00x-100.0%
Bull Case9.0x11.0x$-7.3M$-20.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-7.3M$-24.4M0.00x-100.0%
Bear Case11.0x10.0x$-8.9M$-24.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-8.9M$-29.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumElevated Medicaid exposure (58.1%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
HighElevated distress probabilityModel estimates 66.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 42 hospitals with 50-200 beds
  • Same-state prioritization (n=43)
  • Comp margins: P25=-14.4% / P50=-2.7% / P75=7.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.